60 filings
6-K
SLN
Silence Therapeutics Plc
1 May 24
Current report (foreign)
4:37pm
6-K
SLN
Silence Therapeutics Plc
29 Apr 24
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
8:36am
6-K
SLN
Silence Therapeutics Plc
15 Apr 24
Current report (foreign)
7:00am
6-K
SLN
Silence Therapeutics Plc
13 Mar 24
Current report (foreign)
7:10am
6-K
SLN
Silence Therapeutics Plc
23 Feb 24
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca
8:12am
6-K
jds9ptw5bq lv
6 Feb 24
Securities Purchase Agreement
12:00am
6-K
6wxser
1 Dec 23
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
7:00am
6-K
a76m0 l0a86edqvj2ki
14 Nov 23
Current report (foreign)
12:00am
6-K
ql9 kng72
1 Nov 23
Current report (foreign)
7:00am
6-K/A
9napjams8m6fdd
29 Aug 23
Current report (foreign) (amended)
4:01pm
6-K
x6d0 x19d7
16 Aug 23
Current report (foreign)
7:00am
6-K
s5adnxskov53dfg1nn
11 Jul 23
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
7:00am
6-K
bu74 0kj64d
3 Jul 23
Current report (foreign)
7:30am
6-K
oz6jbjww56prw437bhxd
16 May 23
Current report (foreign)
4:01pm
6-K
xod560jz67hu
4 May 23
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
7:41am
6-K
gce8d 5mcpf
1 May 23
Current report (foreign)
7:31am
6-K
bhq3gz6
27 Apr 23
Current report (foreign)
4:31pm
6-K
02e3012
28 Mar 23
Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
8:00am
6-K
kgmi xmiam8
12 Jan 23
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
4:30pm
6-K
24l12f3 qzxzz
10 Nov 22
Current report (foreign)
8:30am